New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Exercise can reduce severity of breast cancer treatment side effects

Exercise can reduce severity of breast cancer treatment side effects

by Edith Cowan UniversityCredit: Pixabay/CC0 Public DomainBreast cancer is the most common form of the disease among women; in Australia, one in eight women will be diagnosed with breast cancer b
Oncology February 03,2024
Exercise can reduce severity of breast cancer treatment side effects

Exercise can reduce severity of breast cancer treatment side effects

by Edith Cowan UniversityCredit: Pixabay/CC0 Public DomainBreast cancer is the most common form of the disease among women; in Australia, one in eight women will be diagnosed with breast cancer b
Oncology February 03,2024
Some breast cancer treatments may limit effectiveness of weight loss medications

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen
Oncology February 03,2024
Some breast cancer treatments may limit effectiveness of weight loss medications

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen
Oncology February 03,2024
Research reveals potential targets for therapeutic development for glioblastoma

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He
Oncology February 03,2024
Research reveals potential targets for therapeutic development for glioblastoma

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He
Oncology February 03,2024
Survival similar for Black, White prostate cancer patients in clinical trial setting

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati
Oncology February 03,2024
Survival similar for Black, White prostate cancer patients in clinical trial setting

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati
Oncology February 03,2024
Team identifies the cells responsible for colon cancer relapse

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were
Oncology February 03,2024
Team identifies the cells responsible for colon cancer relapse

Team identifies the cells responsible for colon cancer relapse

by Institute for Research in Biomedicine (IRB Barcelona)Colorectal cancer organoids, edited to express a tdTomato reporter in cells with high Epithelial membrane protein 1 (Emp1) expression, were
Oncology February 03,2024
Study explains how 'zombie' cancer cells revive themselves

Study explains how 'zombie' cancer cells revive themselves

by Andrew Smith,Rutgers UniversityGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100293Mutating cells can prevent the spread of cancer by flipping themselve
Oncology February 03,2024
Study explains how 'zombie' cancer cells revive themselves

Study explains how 'zombie' cancer cells revive themselves

by Andrew Smith,Rutgers UniversityGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100293Mutating cells can prevent the spread of cancer by flipping themselve
Oncology February 03,2024
Study provides new look at why rare cancer often evades treatments

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su
Oncology February 03,2024
Study provides new look at why rare cancer often evades treatments

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su
Oncology February 03,2024
Researchers discover crucial step in creating blood stem cells

Researchers discover crucial step in creating blood stem cells

by Iowa State UniversityBlood stem cells show forming in the trunk of a zebrafish embryo. The blood stem cells are yellow, with the red tubes are the aorta on the top and a vein on the bottom. Cr
Oncology February 03,2024
Researchers discover crucial step in creating blood stem cells

Researchers discover crucial step in creating blood stem cells

by Iowa State UniversityBlood stem cells show forming in the trunk of a zebrafish embryo. The blood stem cells are yellow, with the red tubes are the aorta on the top and a vein on the bottom. Cr
Oncology February 03,2024
Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy

Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy

by Walter and Eliza Hall Institute of Medical ResearchGeneration and validation of pdCas9a-SAM construct in Eµ-Myc lymphoma cell lines. a Schematic representation of the pdCas9a-SAM lentiviral co
Oncology February 03,2024
Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy

Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy

by Walter and Eliza Hall Institute of Medical ResearchGeneration and validation of pdCas9a-SAM construct in Eµ-Myc lymphoma cell lines. a Schematic representation of the pdCas9a-SAM lentiviral co
Oncology February 03,2024
Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-
Oncology February 03,2024
Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

Study discovers novel molecular mechanism driving chemoresistance and tumor recurrence in gastric cancer

by The University of Hong KongProposed model for chemoresistance driven by ADAR1-upregulated SCD1 in gastric cancer. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-38581-
Oncology February 03,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com